Philadelphia Eagles quarterback Jalen Hurts has been ruled out for the remainder of the season after a superficial blood clot in his left calf progressed to deep vein thrombosis and bilateral pulmonary emboli. While medical experts confirm the condition is treatable, the mandatory use of blood-thinning medication currently prevents him from playing contact football.
Blood Clots and Anticoagulation Risks for Athletes
- Superficial Vein Thrombosis: A blood clot that forms in a vein close to the surface of the skin, typically residing above the fascia layer of tissue.
- Deep Vein Thrombosis (DVT) & Pulmonary Embolism (PE): A DVT occurs when a clot moves into the deep venous system, while a pulmonary embolism happens if a portion breaks free and travels to block an artery in the lungs.
- Anticoagulation: Medical blood thinners prescribed to prevent existing clots from enlarging or traveling, which simultaneously preclude athletes from participating in contact sports due to severe internal hemorrhage risks.
The Rapid Escalation from a Calf Contusion to Pulmonary Embolism
The timeline of Jalen Hurts’ medical emergency began shortly after an Oct. 4 home loss to the Rams, where the 28-year-old quarterback reported being cleated in the left leg, as noted by the NY Post. On Oct. 8, Hurts requested treatment for his calf. Following an ultrasound on Oct. 10, medical staff diagnosed him with a left calf superficial vein thrombosis.
Despite logging little sleep, Hurts was medically cleared to play and traveled to London, where he started in the Eagles’ game against the Jacksonville Jaguars on Oct. 11. Yahoo Sports reported that doctors subsequently discovered movement in the clot on Oct. 14, indicating it had transitioned into the deep venous system. By Oct. 15, Hurts was ruled out for the upcoming weekend, quickly placed on injured reserve, and ultimately diagnosed with bilateral pulmonary emboli—blood clots in both lungs.
Vascular Mechanics and Risk Factors Behind the Diagnosis
Blood clots generally develop due to a combination of factors, including prolonged immobility from surgery, travel, or illness, underlying clotting disorders, and physical trauma. Dr. William Shutze, vice president of the Society for Vascular Surgery and a vascular surgeon at Texas Vascular Associates, explained to the NY Post that it typically requires two out of these three triggers to provoke a clot.
In Hurts’ case, the initial cleating incident represented physical trauma, while the team’s two seven-hour flights in three days to London introduced prolonged travel immobility. Dr. Thomas Maldonado, a professor of vascular surgery at the NYU Grossman School of Medicine, told Yahoo Sports that superficial clots and deep veins connect behind the knee or in the groin, creating a pathway for a superficial clot to spill into the deep system.
| Diagnosis Stage | Anatomical Location | Clinical Implications |
|---|---|---|
| Superficial Vein Thrombosis | Close to skin, above fascia layer | Initial localized clotting; generally managed without systemic anticoagulation. |
| Deep Vein Thrombosis (DVT) | Deep venous system of the calf/leg | Requires anticoagulation therapy to prevent propagation and embolization. |
| Pulmonary Emboli | Arteries within the lungs | High-risk condition where clots obstruct pulmonary blood flow, halting contact sports participation. |
Treatment Timelines and the Return-to-Play Outlook
Medical experts emphasize that Hurts’ long-term football career is not definitively over, though his immediate return depends entirely on his response to pharmacological intervention. Dr. Shutze noted that the standard minimum duration for blood-thinning therapy is three months, though it can extend to six months if a patient exhibits an elevated risk for recurrent thrombosis.
Dr. Alina Mitina, an emergency medicine physician at Hackensack University Medical Center, explained to the NY Post that patients with persistent clotting disorders may require lifelong anticoagulation, which would permanently preclude a return to professional football. Conversely, Dr. Ben Levine, a professor of internal medicine at UT Southwestern, noted via Yahoo Sports that athletes can safely resume play once their anticoagulation regimen is successfully completed.
An official joint statement from the Philadelphia Eagles and Hurts’ agent, Nicole Lynn, expressed strong optimism regarding his prognosis. The statement confirmed that Hurts is expected to make a full recovery without long-term effects and will remain active around the team, conditioning as he recovers until he is cleared to resume contact activities.
Blood Thinners Increase Risk of Intracranial Hemorrhage
Patients prescribed therapeutic anticoagulants must strictly avoid high-impact collision sports and activities carrying a high risk of falls. Dr. Mitina cautioned that sustaining a head injury or traumatic fall while on blood thinners creates an extreme risk of catastrophic intracranial hemorrhage, or bleeding inside the head.
